Literature DB >> 7688216

Binding of platelet-derived growth factor-BB and transforming growth factor-beta 1 to alpha 2-macroglobulin in vitro and in vivo: comparison of receptor-recognized and non-recognized alpha 2-macroglobulin conformations.

K P Crookston1, D J Webb, J Lamarre, S L Gonias.   

Abstract

alpha 2-Macroglobulin (alpha 2M) undergoes a major conformational change when reacting with proteinases or primary amines. This conformational change has been referred to as the 'slow' to 'fast' transformation based on the increase in alpha 2M mobility shown by non-denaturing PAGE. Previous studies demonstrated that many cytokines, including transforming growth factor beta 1 (TGF-beta 1) and interleukin-1 beta, bind preferentially or exclusively to alpha 2M which has undergone conformational change. In this study, we demonstrate that platelet-derived growth factor-BB (PDGF-BB) also binds preferentially to conformationally transformed alpha 2M (alpha 2M-methylamine, alpha 2M-trypsin) in vitro. Purified 125I-PDGF-BB-alpha 2M-methylamine complex cleared rapidly from the circulation of mice via the alpha 2M receptor/low-density-lipoprotein-receptor-related protein (alpha 2M-R/LRP). In order to determine whether PDGF-BB or TGF-beta 1 binds to native alpha 2M, we defined the native conformation by lack of interaction with alpha 2M-R/LRP instead of electrophoretic mobility. 125I-PDGF-BB was incubated with 4.3 microM native alpha 2M and 0.47 microM alpha 2M-methylamine. The 125I-PDGF-BB distributed evenly between slow-form and fast-form alpha 2M without shifting the electrophoretic mobility of either species. When the mixed preparation was injected intravenously in mice, 125I-PDGF-BB-fast-form-alpha 2M cleared rapidly and selectively from the circulation; 125I-PDGF-BB which was bound to slow-form alpha 2M was stable in the blood (apparently not recognized by alpha 2M-R/LRP). Therefore, while conformationally transformed alpha 2M binds PDGF-BB preferentially in vitro, non-alpha 2M-R/LRP-recognized alpha 2M binds PDGF-BB as well. Binding of 125I-PDGF-BB and 125I-TGF-beta 1 to alpha 2M was demonstrated in vivo by injecting the free growth factors intravenously into mice. Plasma samples which were subjected to non-denaturing PAGE and autoradiography demonstrated binding of both growth factors exclusively to the slow-form of alpha 2M. Therefore, under normal physiological conditions, native alpha 2M (non-alpha 2M-R/LRP-recognized) is the primary form of the proteinase inhibitor functioning as a carrier of PDGF-BB and TGF-beta 1 in the blood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688216      PMCID: PMC1134380          DOI: 10.1042/bj2930443

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Domain structure of human alpha 2-macroglobulin. Characterization of a receptor-binding domain obtained by digestion with papain.

Authors:  L Sottrup-Jensen; J Gliemann; F Van Leuven
Journal:  FEBS Lett       Date:  1986-09-01       Impact factor: 4.124

2.  Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.

Authors:  M D O'Connor-McCourt; L M Wakefield
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

3.  Human transforming growth factor beta.alpha 2-macroglobulin complex is a latent form of transforming growth factor beta.

Authors:  S S Huang; P O'Grady; J S Huang
Journal:  J Biol Chem       Date:  1988-01-25       Impact factor: 5.157

4.  Analysis of thiolester bond cleavage-dependent conformational changes in binary alpha 2-macroglobulin-proteinase complexes.

Authors:  P A Roche; S V Pizzo
Journal:  Arch Biochem Biophys       Date:  1988-11-15       Impact factor: 4.013

5.  Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin.

Authors:  W Borth; T A Luger
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

6.  Inhibition of plasmin activity by alpha-2-macroglobulin.

Authors:  P O Ganrot
Journal:  Clin Chim Acta       Date:  1967-05       Impact factor: 3.786

7.  Purification of type-beta transforming growth factor from human platelets.

Authors:  R K Assoian
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

8.  Thrombin-induced conformational changes of human alpha 2-macroglobulin: evidence for two functional domains.

Authors:  J P Steiner; P Bhattacharya; D K Strickland
Journal:  Biochemistry       Date:  1985-06-04       Impact factor: 3.162

9.  Identification of a monoclonal antibody specific for a neoantigenic determinant on alpha 2-macroglobulin: use for the purification and characterization of binary proteinase-inhibitor complexes.

Authors:  D K Strickland; J P Steiner; M Migliorini; F D Battey
Journal:  Biochemistry       Date:  1988-03-08       Impact factor: 3.162

10.  Preparation and binding of radioactively labeled porcine transforming growth factor type beta.

Authors:  E Ruff; A Rizzino
Journal:  Biochem Biophys Res Commun       Date:  1986-07-31       Impact factor: 3.575

View more
  14 in total

Review 1.  Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.

Authors:  Marco Dieckmann; Martin Frederik Dietrich; Joachim Herz
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 2.  New strategies for treatment of pulmonary fibrosis.

Authors:  S H Phan
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

Review 3.  Design of growth factor sequestering biomaterials.

Authors:  David G Belair; Ngoc Nhi Le; William L Murphy
Journal:  Chem Commun (Camb)       Date:  2014-09-03       Impact factor: 6.222

4.  Proteinases are isoform-specific regulators of the binding of transforming growth factor beta to alpha 2-macroglobulin.

Authors:  D J Webb; A M Weaver; T L Atkins-Brady; S L Gonias
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

5.  Structural and functional analysis of the spontaneous re-formation of the thiol ester bond in human alpha 2-macroglobulin, rat alpha 1-inhibitor-3 and chemically modified derivatives.

Authors:  H Grøn; I B Thøgersen; J J Enghild; S V Pizzo
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

6.  alpha 2-macroglobulin stimulation of protein tyrosine phosphorylation in macrophages via the mannose receptor for Fc gamma receptor-mediated phagocytosis activation.

Authors:  M Murai; Y Aramaki; S Tsuchiya
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

7.  Effect of implantation of Augment(®) Bone Graft on serum concentrations of platelet-derived growth factors: a pharmacokinetic study.

Authors:  Luis A Solchaga; Timothy Daniels; Stephen Roach; William Beasley; Leo B Snel
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

8.  Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.

Authors:  D J Webb; K P Crookston; N L Figler; J Lamarre; S L Gonias
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

9.  Hepcidin bound to α2-macroglobulin reduces ferroportin-1 expression and enhances its activity at reducing serum iron levels.

Authors:  Michael Li-Hsuan Huang; Christopher J D Austin; Marie-Agnès Sari; Yohan Suryo Rahmanto; Prem Ponka; Daniel Vyoral; Des R Richardson
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

10.  Mammalian transforming growth factor beta1 activated after ingestion by Anopheles stephensi modulates mosquito immunity.

Authors:  Shirley Luckhart; Andrea L Crampton; Ruben Zamora; Matthew J Lieber; Patricia C Dos Santos; Tina M L Peterson; Nicole Emmith; Junghwa Lim; David A Wink; Yoram Vodovotz
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.